PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 138 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $200 | -69.4% | 12,000 | -49.4% | 0.00% | -66.7% |
Q2 2023 | $654 | -50.1% | 23,700 | -58.4% | 0.00% | +50.0% |
Q1 2023 | $1,310 | +689.2% | 57,000 | +272.5% | 0.00% | +100.0% |
Q4 2022 | $166 | -99.9% | 15,300 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $128,000 | +5.8% | 15,300 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $121,000 | -59.7% | 15,300 | +20.5% | 0.00% | 0.0% |
Q1 2022 | $300,000 | -33.5% | 12,700 | -3.8% | 0.00% | -50.0% |
Q4 2021 | $451,000 | +93.6% | 13,200 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $233,000 | -40.9% | 13,200 | +50.0% | 0.00% | 0.0% |
Q2 2021 | $394,000 | +52.1% | 8,800 | -12.0% | 0.00% | 0.0% |
Q1 2021 | $259,000 | +28.9% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $201,000 | -42.4% | 10,000 | -49.5% | 0.00% | -50.0% |
Q2 2020 | $349,000 | +181.5% | 19,800 | +12.5% | 0.00% | +100.0% |
Q1 2020 | $124,000 | 0.0% | 17,600 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $124,000 | +5.1% | 17,600 | +27.5% | 0.00% | 0.0% |
Q1 2018 | $118,000 | +140.8% | 13,800 | +475.0% | 0.00% | – |
Q4 2017 | $49,000 | +16.7% | 2,400 | 0.0% | 0.00% | – |
Q3 2017 | $42,000 | +55.6% | 2,400 | 0.0% | 0.00% | – |
Q2 2017 | $27,000 | -10.0% | 2,400 | 0.0% | 0.00% | – |
Q1 2017 | $30,000 | -42.3% | 2,400 | 0.0% | 0.00% | – |
Q4 2016 | $52,000 | +4.0% | 2,400 | 0.0% | 0.00% | – |
Q3 2016 | $50,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |